NEW YORK, July 5 (GenomeWeb News) - Alpha Innotech expects to report at least $3.15 million in revenues for the quarter ended June 30, marking its fourth consecutive quarter of year-over-year revenue growth, the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.